NO975423L - Anti-sense oligonukleotider for blokkering av IgE-reseptorsyntese - Google Patents
Anti-sense oligonukleotider for blokkering av IgE-reseptorsynteseInfo
- Publication number
- NO975423L NO975423L NO975423A NO975423A NO975423L NO 975423 L NO975423 L NO 975423L NO 975423 A NO975423 A NO 975423A NO 975423 A NO975423 A NO 975423A NO 975423 L NO975423 L NO 975423L
- Authority
- NO
- Norway
- Prior art keywords
- sense oligonucleotides
- ige receptor
- receptor synthesis
- blocking ige
- blocking
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1138—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against receptors or cell surface proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/315—Phosphorothioates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/33—Chemical structure of the base
- C12N2310/337—Chemical structure of the base in alpha-anomeric form
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/35—Nature of the modification
- C12N2310/351—Conjugate
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/35—Nature of the modification
- C12N2310/351—Conjugate
- C12N2310/3515—Lipophilic moiety, e.g. cholesterol
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9510718.1A GB9510718D0 (en) | 1995-05-26 | 1995-05-26 | Antisense oligonucleotides |
PCT/FR1996/000785 WO1996037605A2 (fr) | 1995-05-26 | 1996-05-24 | OLIGONUCLEOTIDES ANTISENS POUR BLOQUER LA SYNTHESE DU RECEPTEUR DE L'IgE |
Publications (2)
Publication Number | Publication Date |
---|---|
NO975423L true NO975423L (no) | 1997-11-25 |
NO975423D0 NO975423D0 (no) | 1997-11-25 |
Family
ID=10775100
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO975423A NO975423D0 (no) | 1995-05-26 | 1997-11-25 | Anti-sense oligonukleotider for blokkering av IgE-reseptorsyntese |
Country Status (7)
Country | Link |
---|---|
US (1) | US5892023A (fr) |
EP (1) | EP0828827A2 (fr) |
AU (1) | AU6008296A (fr) |
CA (1) | CA2222197A1 (fr) |
GB (1) | GB9510718D0 (fr) |
NO (1) | NO975423D0 (fr) |
WO (1) | WO1996037605A2 (fr) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6784291B2 (en) * | 2000-05-04 | 2004-08-31 | Avi Biopharma, Inc. | Splice-region antisense composition and method |
WO2004025483A1 (fr) * | 2002-09-16 | 2004-03-25 | Commvault Systems, Inc. | Systeme et procede permettant d'optimiser des operations de stockage |
US20080311556A1 (en) * | 2003-08-07 | 2008-12-18 | Iversen Patrick L | Sense Antiviral Compound and Method for Treating Ssrna Viral Infection |
US20050222068A1 (en) * | 2003-10-23 | 2005-10-06 | Mourich Dan V | Method and antisense composition for selective inhibition of HIV infection in hematopoietic cells |
US20050171044A1 (en) * | 2003-12-24 | 2005-08-04 | Stein David A. | Oligonucleotide compound and method for treating nidovirus infections |
US20050234002A1 (en) * | 2004-01-23 | 2005-10-20 | Mourich Dan V | Antisense oligomers and methods for inducing immune tolerance and immunosuppression |
EP1737956A2 (fr) * | 2004-03-01 | 2007-01-03 | Massachusetts Institute of Technology | Agents therapeutiques a base d'arni pour le traitement de la rhinite allergique et de l'asthme |
ATE498685T1 (de) | 2004-06-28 | 2011-03-15 | Univ Western Australia | Antisense-oligonukleotide zur induktion von exon- skipping sowie verfahren zur verwendung davon |
USRE48960E1 (en) | 2004-06-28 | 2022-03-08 | The University Of Western Australia | Antisense oligonucleotides for inducing exon skipping and methods of use thereof |
CA2571593C (fr) * | 2004-07-02 | 2015-04-21 | Avi Biopharma, Inc. | Technique et compose antibacterien antisens |
US8129352B2 (en) * | 2004-09-16 | 2012-03-06 | Avi Biopharma, Inc. | Antisense antiviral compound and method for treating ssRNA viral infection |
US8357664B2 (en) | 2004-10-26 | 2013-01-22 | Avi Biopharma, Inc. | Antisense antiviral compound and method for treating influenza viral infection |
US7524829B2 (en) * | 2004-11-01 | 2009-04-28 | Avi Biopharma, Inc. | Antisense antiviral compounds and methods for treating a filovirus infection |
US20060240032A1 (en) * | 2005-03-31 | 2006-10-26 | Hinrichs David J | Immunomodulating compositions and methods for use in the treatment of human autoimmune diseases |
US8067571B2 (en) * | 2005-07-13 | 2011-11-29 | Avi Biopharma, Inc. | Antibacterial antisense oligonucleotide and method |
WO2007030691A2 (fr) * | 2005-09-08 | 2007-03-15 | Avi Biopharma, Inc. | Compose antisens antiviral et procede de traitement d'infection picornavirale |
EP1937278B1 (fr) * | 2005-09-08 | 2012-07-25 | AVI BioPharma, Inc. | Compose antisens antiviral et procede de traitement d'infection picornavirale |
US8501704B2 (en) | 2005-11-08 | 2013-08-06 | Sarepta Therapeutics, Inc. | Immunosuppression compound and treatment method |
US8785407B2 (en) * | 2006-05-10 | 2014-07-22 | Sarepta Therapeutics, Inc. | Antisense antiviral agent and method for treating ssRNA viral infection |
LT2735568T (lt) | 2006-05-10 | 2017-11-27 | Sarepta Therapeutics, Inc. | Oligonukleotido analogai, turintys katijonines jungtis tarp subvienetų |
CA2710013A1 (fr) * | 2007-12-28 | 2009-07-09 | Avi Biopharma, Inc. | Agents immunomodulatoires et procedes d'utilisation |
CN102203253B (zh) | 2008-10-24 | 2016-04-06 | 萨雷普塔治疗公司 | 用于dmd的多外显子跳跃组合物 |
EP2376633A1 (fr) * | 2008-12-17 | 2011-10-19 | AVI BioPharma, Inc. | Compositions antisens et méthodes de modulation de l'hypersensibilité de contact ou de la dermatite de contact |
CN105838714B (zh) | 2009-11-12 | 2020-07-17 | 西澳大利亚大学 | 反义分子和治疗疾病的方法 |
US8697858B2 (en) | 2009-11-13 | 2014-04-15 | Sarepta Therapeutics, Inc. | Antisense antiviral compound and method for treating influenza viral infection |
KR101981705B1 (ko) | 2010-05-28 | 2019-05-24 | 사렙타 쎄러퓨틱스, 인코퍼레이티드 | 변형된 서브유니트간 결합 및/또는 말단 그룹을 갖는 올리고뉴클레오타이드 유사체 |
US8198429B2 (en) | 2010-08-09 | 2012-06-12 | Avi Biopharma, Inc. | Antisense antiviral compounds and methods for treating a filovirus infection |
US10017763B2 (en) | 2010-09-03 | 2018-07-10 | Sarepta Therapeutics, Inc. | dsRNA molecules comprising oligonucleotide analogs having modified intersubunit linkages and/or terminal groups |
MX354940B (es) | 2011-11-18 | 2018-03-27 | Sarepta Therapeutics Inc | Oligonucleotidos funcionalmente modificados y subunidades de los mismos. |
BR122020016865B1 (pt) | 2013-03-14 | 2022-12-27 | Sarepta Therapeutics, Inc. | Oligonucleotídeo antisenso, composição farmacêutica compreendendo o mesmo e uso da dita composição para o tratamento de distrofia muscular de duchenne (dmd) |
CA2906812A1 (fr) | 2013-03-15 | 2014-09-18 | Sarepta Therapeutics, Inc. | Compositions ameliorees pour le traitement de la dystrophie musculaire |
WO2016196897A1 (fr) | 2015-06-04 | 2016-12-08 | Sarepta Therapeutics, Inc. | Procédés et composés pour le traitement de maladies et d'états pathologiques associés aux lymphocytes |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5770396A (en) * | 1992-04-16 | 1998-06-23 | The United States Of America As Represented By The Department Of Health And Human Services | Isolation characterization, and use of the human beta subunit of the high affinity receptor for immunoglobulin E |
IL111105A (en) * | 1993-09-30 | 2009-05-04 | Univ Pennsylvania | Use of a molecule capable of inhibiting the expression of syk kinase to prepare a pharmaceutical composition for inhibiting phagocytosis |
-
1995
- 1995-05-26 GB GBGB9510718.1A patent/GB9510718D0/en active Pending
-
1996
- 1996-05-24 EP EP96917549A patent/EP0828827A2/fr not_active Withdrawn
- 1996-05-24 CA CA002222197A patent/CA2222197A1/fr not_active Abandoned
- 1996-05-24 WO PCT/FR1996/000785 patent/WO1996037605A2/fr not_active Application Discontinuation
- 1996-05-24 US US08/952,597 patent/US5892023A/en not_active Expired - Fee Related
- 1996-05-24 AU AU60082/96A patent/AU6008296A/en not_active Abandoned
-
1997
- 1997-11-25 NO NO975423A patent/NO975423D0/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO1996037605A2 (fr) | 1996-11-28 |
AU6008296A (en) | 1996-12-11 |
EP0828827A2 (fr) | 1998-03-18 |
WO1996037605A3 (fr) | 1996-12-27 |
US5892023A (en) | 1999-04-06 |
CA2222197A1 (fr) | 1996-11-28 |
NO975423D0 (no) | 1997-11-25 |
GB9510718D0 (en) | 1995-07-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO975423L (no) | Anti-sense oligonukleotider for blokkering av IgE-reseptorsyntese | |
BR9608884A (pt) | Anticorpos monoclonais humanos de alta afinidade específicos para proteína-F rsv | |
DE59601328D1 (de) | Chirurgischer Wundsperrer | |
DE69626167D1 (de) | Chirurgischer Retraktor | |
DE69624227D1 (de) | Substanzabgabevorrichtung | |
BR9607123A (pt) | Unidade de plantio | |
DE69635379D1 (de) | Atm-drosselung | |
BR9612327A (pt) | Antagonistas receptores de vitronectina | |
PT876482E (pt) | Polipeptideo receptor de il-13 | |
DE69618412D1 (de) | Gurtaufroller | |
FI973086A0 (fi) | Parannettu syklopropyyliasetyleenisynteesi | |
DE69631966D1 (de) | Sicherheitsgurtaufroller | |
DE69636018D1 (de) | Abgabevorrichtung | |
FR2737885B3 (fr) | Distributeur de comprimes | |
DE69609448D1 (de) | Luftsack | |
DE69603317D1 (de) | Münzausgabevorrichtung | |
KR970000325U (ko) | 소형 떡시루 셋트 | |
DK143095A (da) | Tyverisikring af hukommelsesprodukter | |
DE69606203D1 (de) | Sähmaschine | |
KR970017397U (ko) | 에어백 | |
DE59604362D1 (de) | Direktsämaschine | |
DE59601327D1 (de) | Sämaschine | |
KR970020361U (ko) | 개량 파종기 | |
KR970045755U (ko) | 자동 판매기의 상품투출 구조 | |
KR960030213U (ko) | 무쓰용 빗 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |